# Molecular Effects of Topical Calcipotriene on Morphea

> **NCT02411643** · EARLY_PHASE1 · TERMINATED · sponsor: **Northwestern University** · enrollment: 2 (actual)

## Conditions studied

- Morphea
- Localized Scleroderma

## Interventions

- **DRUG:** topical calcipotriene 0.005% ointment

## Key facts

- **NCT ID:** NCT02411643
- **Lead sponsor:** Northwestern University
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2015-03
- **Primary completion:** 2016-04
- **Final completion:** 2016-04
- **Target enrollment:** 2 (ACTUAL)
- **Why stopped:** Accrual incomplete/Investigator left institution
- **Last updated:** 2018-09-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02411643

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02411643, "Molecular Effects of Topical Calcipotriene on Morphea". Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/clinical/NCT02411643. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*